Testosterone therapy may reduce prostate cancer risk due to testosterone deficiency at a young age via stabilizing serum testosterone levels

References

• American Cancer Society. Prostate Cancer Risk Factors. 2014;1–2. [cited 2017 Dec 15]. Available from: https://www.cancer.org/content/cancer/en/cancer/prostate-cancer/causes-risks-prevention/risk-factors/.
   Google Scholar
• Harman SM, Metter EJ, Tobin JD, et al. Longitudinal effects of aging on serum total and free testosterone levels in healthy men. J Clin Endocrinol Metab. 2001;86:724–731.
   PubMed Web of Science ®Google Scholar
• Kaplan AL, Hu JC, Morgentaler A, et al. Testosterone therapy in men with prostate cancer. Eur Urol. 2016;69:894–903.
   PubMed Web of Science ®Google Scholar
• Corona G, Mannucci E, Ricca V, et al. The age-related decline of testosterone is associated with different specific symptoms and signs in patients with sexual dysfunction. Int J Androl. 2009;32:720–728.
   PubMedGoogle Scholar
• Xu X, Zhang X, Zhong Y, et al. Dynamic patterns of testosterone levels in individuals and risk of prostate cancer among hypogonadal men: a longitudinal study. J Urol. 2018;199:465–473.
   PubMed Web of Science ®Google Scholar
• St. Sauver JL, Jacobson DJ, McGree ME, et al. Associations between longitudinal changes in serum estrogen, testosterone, and bioavailable testosterone and changes in benign urologic outcomes. Am J Epidemiol. 2011;173:787–796.
   PubMed Web of Science ®Google Scholar
• Khera M, Crawford D, Morales A, et al. A new era of testosterone and prostate cancer: from physiology to clinical implications. Eur Urol. 2014;65:115–123.
   PubMed Web of Science ®Google Scholar
• Claps M, Petrelli F, Caffo O, et al. Testosterone levels and prostate cancer prognosis: systematic review and meta-analysis. Clin Genitourin Cancer. 2018. [cited 2018 May 7]. Available from: http://linkinghub.elsevier.com/retrieve/pii/S1558767318300326
   PubMed Web of Science ®Google Scholar
• Yassin A, Salman M, Talib RA, et al. Is there a protective role of testosterone against high-grade prostate cancer? Incidence and severity of prostate cancer in 553 patients who underwent prostate biopsy: a prospective data register. Aging Male. 2017;20:125–133.
   PubMed Web of Science ®Google Scholar
• Huggins H, Hodges CV. Studies on prostatic cancer. I. The effect of castration, of estrogen, and of androgen injection on serum phosphatases in metastatic carcinoma of the prostate. Cancer Res. 1941;1:293.
   Google Scholar
• Yassin A, AlRumaihi K, Alzubaidi R, et al. Testosterone, testosterone therapy and prostate cancer. Aging Male. 2019;0:1–9.
   Google Scholar
• Bhasin S, Pencina M, Jasuja GK, et al. Reference ranges for testosterone in men generated using liquid chromatography tandem mass spectrometry in a community-based sample of healthy nonobese young men in the framingham heart study and applied to three geographically distinct cohorts. J Clin Endocrinol Metab. 2011;96:2430–2439.
   PubMed Web of Science ®Google Scholar
• Traish AM, Haider A, Haider KS, et al. Long-term testosterone therapy improves cardiometabolic function and reduces risk of cardiovascular disease in men with hypogonadism. J Cardiovasc Pharmacol Ther. 2017;22:414–443.
   PubMed Web of Science ®Google Scholar
• Haider KS, Haider A, Doros G, et al. Long-term testosterone therapy improves urinary and sexual function, and quality of life in men with hypogonadism: results from a propensity matched subgroup of a controlled registry study. J Urol. 2018;199:257–265.
   PubMed Web of Science ®Google Scholar
• Aus G, Abbou CC, Bolla M, et al. EAU Guidelines on Prostate Cancer. Eur Urol. 2005;48:546–551.
   PubMed Web of Science ®Google Scholar
• Arduino LJ. Carcinoma of the prostate in sex chromatin positive (XXX/XY) Klinefelter's syndrome. J Urol. 1967;98:234–240.
   PubMed Web of Science ®Google Scholar
• Bydder SA, Joseph DJ, Weinstein S, et al. Prostate cancer following testosterone replacement in Klinefelter syndrome. ANZ J Surg. 2007;77:93–94.
   PubMed Web of Science ®Google Scholar
• Hwang JJ, Dharmawardana PG, Uchio EM, et al. Prostate cancer in Klinefelter syndrome during hormonal replacement therapy. Urology. 2003;62:941.
   PubMed Web of Science ®Google Scholar
• Zakaria AS, Dragomir A, Kassouf W, et al. Changes in the levels of testosterone profile over time in relation to clinical parameters in a cohort of patients with prostate cancer managed by active surveillance. World J Urol. 2018;36:1209–1217.
   PubMed Web of Science ®Google Scholar
• Mearini L, Zucchi A, Nunzi E, et al. Low serum testosterone levels are predictive of prostate cancer. World J Urol. 2013;31:247–252.
   PubMed Web of Science ®Google Scholar
• Gurbuz C, Canat L, Atis G, et al. The role of serum testosterone to prostate-specific antigen ratio as a predictor of prostate cancer risk. Kaohsiung J Med Sci. 2012;28:649–653.
   PubMed Web of Science ®Google Scholar
• Gooren LJ, Behre HM, Saad F, et al. Diagnosing and treating testosterone deficiency in different parts of the world. Results from global market research. Aging Male. 2007;10:173–181.
   PubMed Web of Science ®Google Scholar
• Marks LS, Mazer NA, Mostaghel E, et al. Effect of testosterone replacement therapy on prostate tissue in men with late-onset hypogonadism. JAMA. 2006;296:2351.
   PubMed Web of Science ®Google Scholar
• Shabsigh R, Crawford ED, Nehra A, et al. Testosterone therapy in hypogonadal men and potential prostate cancer risk: a systematic review. Int J Impot Res. 2009;21:9–23.
   PubMed Web of Science ®Google Scholar
• Pastuszak AW, Pearlman AM, Godoy G, et al. Testosterone replacement therapy in the setting of prostate cancer treated with radiation. Int J Impot Res. 2013;25:24–28.
   PubMed Web of Science ®Google Scholar
• Golla V, Kaplan AL. Testosterone therapy on active surveillance and following definitive treatment for prostate cancer. Curr Urol Rep. 2017;18:49.
   PubMed Web of Science ®Google Scholar
• Walsh TJ, Shores MM, Krakauer CA, et al. Testosterone treatment and the risk of aggressive prostate cancer in men with low testosterone levels. PLoS One. 2018;13:e0199194.
   PubMed Web of Science ®Google Scholar
• Baillargeon J, Kuo Y-F, Fang X, et al. Long-term exposure to testosterone therapy and the risk of high grade prostate cancer. J Urol. 2015;194:1612–1616.
   PubMed Web of Science ®Google Scholar
• Corona G, Monami M, Rastrelli G, et al. Testosterone and metabolic syndrome: a meta-analysis study. J Sex Med. 2011;8:272–283.
   PubMed Web of Science ®Google Scholar
• Rabijewski M, Papierska L, Piątkiewicz P, et al. The aging male the prevalence of prediabetes in population of Polish men with late-onset hypogonadism. The prevalence of prediabetes in population of Polish men with late-onset hypogonadism. Aging Male. 2014;17:1368–5538.
   Web of Science ®Google Scholar
• Saad F, Yassin A, Doros G, et al. Effects of long-term treatment with testosterone on weight and waist size in 411 hypogonadal men with obesity classes I-III: observational data from two registry studies. Int J Obes. 2016;40:162–170.
   PubMed Web of Science ®Google Scholar
• Wang C, Nieschlag E, Swerdloff R, et al. Investigation, treatment, and monitoring of late-onset hypogonadism in males: ISA, ISSAM, EAU, EAA, and ASA recommendations. J Androl. 2009;30:1–9.
   PubMedGoogle Scholar
• Klap J, Schmid M, Loughlin KR. The relationship between total testosterone levels and prostate cancer: a review of the continuing controversy. J Urol. 2015;193:403–413.
   PubMedGoogle Scholar
• Xu X, Chen X, Hu H, et al. Current opinion on the role of testosterone in the development of prostate cancer: a dynamic model. BMC Cancer. 2015;15:806.
   PubMed Web of Science ®Google Scholar
• Feldman HA, Longcope C, Derby CA, et al. Age trends in the level of serum testosterone and other hormones in middle-aged men: longitudinal results from the Massachusetts Male Aging Study. J Clin Endocrinol Metab. 2002;87:589–598.
   PubMed Web of Science ®Google Scholar
• Gencer B, Mach F. Testosterone: a hormone preventing cardiovascular disease or a therapy increasing cardiovascular events? Eur Heart J. 2016;37:3569–3575.
   PubMed Web of Science ®Google Scholar
• Júnior AN, Szelbracikowski S. d S, Nardi AC, et al. Age-related testosterone decline in a Brazilian cohort of healthy military men. Int Braz J Urol. 2011;37:591–597.
   PubMed Web of Science ®Google Scholar